Unfortunately, no news flow is really expected for at least six...

Unfortunately, no news flow is really expected for at least six months to a year-plus.

Most people need to see to believe which means I highly doubt we will have any movement in SP whilst we are in limbo.

Amazing opportunity to buy in the dips.

2024 expected news flow (source: AGM presentation)
1. Full recruitment to international phase IIb study of ATL1102 in Duchenne muscular dystrophy1H CY2024(looking shaky??)
2. Completion of ‘in life’ phase of 9-month non-human primate toxicology study1H CY2024
3. Publication in peer-reviewed journal of full data from phase IIa study of ATL1102 in Duchenne muscular dystrophy1H CY2024
4. Initial data from international phase IIb study of ATL1102 in Duchenne muscular dystrophy2H CY2024 (linked to point one)

Outside the box... possible joint strategy mid-2024??